Using Patient Feedback to Improve Medication Strategies for Opioid Use Disorder
Accredited for 1.0 AMA PRA Category 1 Credits™
Wednesday, June 11, 2025
7 – 8 p.m. ET
Members: FREE
Nonmembers: $75
Registration required.
Program description:
This educational program offers a comprehensive overview of current best practices and emerging strategies for treating opioid use disorder. Participants will explore the latest developments in buprenorphine initiation, including practical approaches to new induction methods and the use of long-acting injectable formulations. The program emphasizes shared decision-making to support patient-centered care. It will also examine the treatment landscape in Indiana, highlighting effective strategies for helping patients navigate gaps in care and transitions between providers. Finally, attendees will review evidence on how stigma in the health care system creates barriers to treatment and learn actionable steps to provide more compassionate, effective care for individuals who use drugs.
Objectives:
At the end of this live webinar, attendees will be able to:
- Review developments in the treatment of opioid use disorder, including a practical approach to novel buprenorphine initiation strategies, long-acting injectable buprenorphine and shared decision-making with patients.
- Identify the treatment landscape in Indiana and strategies for helping patients navigate into care through gaps in care and between treatment providers.
- Explain the evidence around how persistent stigma within the healthcare system keeps patients from accessing life-saving treatment and what can be done to help drive more positive and effective interactions with people who use drugs.
Speaker:
Krista Brucker, MD
Emergency and Addiction Medicine
About the speaker:
Krista Brucker, MD, is an emergency medicine physician with South Bend Emergency Physicians and an addiction medicine physician at Oaklawn Psychiatric Center in South Bend, Indiana. She previously served on the faculty of the Indiana University School of Medicine’s Department of Emergency Medicine, where she developed and implemented Project POINT, an education-based intervention for people who survived an opioid overdose. Her clinical work and research focus on improving urgent access to mental health and substance use disorder treatment. She is the founding physician of the Oaklawn Addiction Medicine program and has served as a regional medical director for a large telehealth addiction medicine provider.
CME INFORMATION
Designation Statement: The Indiana State Medical Association (ISMA) designates this live webinar for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Accreditation Statement: The Indiana State Medical Association (ISMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Disclosure Policy: In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by the ISMA must demonstrate balance, independence, objectivity and scientific rigor. Prior to the activity, all faculty, authors, editors and planning committee members participating in an ISMA-sponsored activity are required to disclose to attendees any relevant financial relationships with an “ineligible company” whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Disclosure Statement: No member of the CME Planning Committee or our speaker have any relevant financial relationships to disclose.
If you have questions, contact ISMA Continuing Medical Education staff at 800-257-4762 or seminars@ismanet.org.
REGISTRATION DEADLINE: June 11, 2025 at 6:30 p.m. ET